ST. PAUL, Minn., Feb. 26, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) will host an investor day on Thursday, March 20, 2025, beginning at approximately 1:00 p.m. Eastern Standard Time. The event will be held in New York City and simultaneously webcast online.
More information about this event, including registration information, may be accessed by visiting https://investors.solventum.com. The webcast replay will be available shortly after the live webcast ends.
About Solventum
At Solventum, we enable better, smarter, safer healthcare to improve lives. As a new company with a long legacy of creating breakthrough solutions for our customers' toughest challenges, we pioneer game-changing innovations at the intersection of health, material and data science that change patients' lives for the better — while empowering healthcare professionals to perform at their best. See how at Solventum.com.
| Last Trade: | US$76.19 |
| Daily Change: | 0.53 0.70 |
| Daily Volume: | 975,281 |
| Market Cap: | US$13.220B |
November 06, 2025 October 21, 2025 August 07, 2025 | |
Amneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MORE
Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MORE
